196 related articles for article (PubMed ID: 37280272)
1. Hyperglycemia-activated 11β-hydroxysteroid dehydrogenase type 1 increases endoplasmic reticulum stress and skin barrier dysfunction.
Lee YB; Hwang HJ; Kim E; Lim SH; Chung CH; Choi EH
Sci Rep; 2023 Jun; 13(1):9206. PubMed ID: 37280272
[TBL] [Abstract][Full Text] [Related]
2. Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.
Kim BJ; Lee NR; Lee CH; Lee YB; Choe SJ; Lee S; Hwang HJ; Kim E; Lavery GG; Shin KO; Park K; Choi EH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072239
[TBL] [Abstract][Full Text] [Related]
3. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
[TBL] [Abstract][Full Text] [Related]
4. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
[TBL] [Abstract][Full Text] [Related]
5. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes.
Itoi S; Terao M; Murota H; Katayama I
Biochem Biophys Res Commun; 2013 Oct; 440(2):265-70. PubMed ID: 24055708
[TBL] [Abstract][Full Text] [Related]
6. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
Wang Y; Nakagawa Y; Liu L; Wang W; Ren X; Anghel A; Lutfy K; Friedman TC; Liu Y
Diabetologia; 2011 Feb; 54(2):440-50. PubMed ID: 21052977
[TBL] [Abstract][Full Text] [Related]
8. UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo.
Tiganescu A; Hupe M; Jiang YJ; Celli A; Uchida Y; Mauro TM; Bikle DD; Elias PM; Holleran WM
Exp Dermatol; 2015 May; 24(5):370-6. PubMed ID: 25739654
[TBL] [Abstract][Full Text] [Related]
9. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.
Liu Y; Nakagawa Y; Wang Y; Li R; Li X; Ohzeki T; Friedman TC
Diabetes; 2003 Jun; 52(6):1409-16. PubMed ID: 12765951
[TBL] [Abstract][Full Text] [Related]
10. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
[TBL] [Abstract][Full Text] [Related]
11. Local cortisol/corticosterone activation in skin physiology and pathology.
Terao M; Katayama I
J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing.
Brazel CB; Simon JC; Tuckermann JP; Saalbach A
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260645
[TBL] [Abstract][Full Text] [Related]
13. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
Lee SE; Lee EY; Kang SJ; Lee SH
Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
[TBL] [Abstract][Full Text] [Related]
14. Psychological Stress Deteriorates Skin Barrier Function by Activating 11β-Hydroxysteroid Dehydrogenase 1 and the HPA Axis.
Choe SJ; Kim D; Kim EJ; Ahn JS; Choi EJ; Son ED; Lee TR; Choi EH
Sci Rep; 2018 Apr; 8(1):6334. PubMed ID: 29679067
[TBL] [Abstract][Full Text] [Related]
15. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
[TBL] [Abstract][Full Text] [Related]
16. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.
Paterson JM; Holmes MC; Kenyon CJ; Carter R; Mullins JJ; Seckl JR
Endocrinology; 2007 Mar; 148(3):961-6. PubMed ID: 17170103
[TBL] [Abstract][Full Text] [Related]
17. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.
Tiganescu A; Walker EA; Hardy RS; Mayes AE; Stewart PM
J Invest Dermatol; 2011 Jan; 131(1):30-6. PubMed ID: 20739946
[TBL] [Abstract][Full Text] [Related]
18. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
19. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
[TBL] [Abstract][Full Text] [Related]
20. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.
Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ
Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
